Fred Hutchinson Cancer Center is at the forefront of a fundamental shift in how cancer is treated and cured. At Fred Hutch, PICI researcher Philip Greenberg, MD, develops new ways to empower a patient’s immune system to eradicate cancer. With PICI, he uses mouse models to characterize and test translatable strategies to treat many cancers. He also develops more effective T-cells to treat ovarian cancer through adoptive cell therapy. Tijana Martinov, PhD, a Parker Scholar in Greenberg’s lab, designs and tests T-cells that target and destroy multiple myeloma in mouse models. Philip Greenberg, MD | Investigator Tijana Martinov, PhD | Parker Scholar Related Research Focus CAR-T and Cell Therapy: The Next Wave Announcement PICI Welcomes New UCSF Center Director Announcement New Staff Members Join PICI Announcement PICI Members and Partners Featured at #CARTCR Announcement, Our Impact PICI Network Researchers Featured at #IO23ASGCT Announcement, Our Impact, Press Release Developing Next-Gen Scientific Leaders Announcement, Our Impact PICI Network Researchers at #ASCO23 Announcement, Partner Highlight Guardant Health, PICI Launch Research Collaboration Announcement, Our Impact PICI Network Researchers at #AACR23